The Qatar Red Crescent Society (QRCS) has recently launched a project to provide essential cancer drugs, valued at $1 million, to internally displaced people (IDP) and local communities in northern Syria. The project, which is expected to last five months, aims to meet the needs of cancer patients in the region.
The initiative includes the provision of early diagnosis and treatment equipment, as well as capacity-building for 25 medical professionals at the cancer centers in the target areas. The project is being implemented in Idlib by QRCS’s representation office in Gaziantep, Turkey.
The project is estimated to serve 3,700 direct beneficiaries and 18,500 indirect beneficiaries. It aims to improve health conditions and reduce mortality rates among cancer patients in northern Syria by enhancing their access to healthcare services.
According to the project’s action plan, the medical supplies were stored at QRCS’s warehouses in northern Syria. They will later be delivered to the Idlib Health Directorate, which will distribute them to cancer centers across the northern parts of the country.
The supplies include 46 types of expensive chemotherapy and immunotherapy drugs (12,000 intravenous doses and 32,000 oral doses), pharmaceutical mixers, digital microscopes, water heaters, pharmaceutical refrigerators, and dry heat sterilizers.
In addition to the provision of medical supplies, mental health and psychosocial trainers have been hired to train the medical professionals working at the oncology centers. They will offer psychological first aid (PFA) and mental health interventions to cancer patients and their families.
Socioeconomically, this project is expected to make a significant difference in the lives of many cancer patients. By filling the gap in supply chains for cancer centers, it ensures the continuity of life-saving specialized and free-of-charge medical services.
A global media for the latest news, entertainment, music fashion, and more.
